Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer

Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer and triple-negative breast cancer have their own genetic, epigenetic, and protein expression profiles. In the present study, based on bioinformatics techniques, we explored the prognostic targets of HER2-positive breast cancer fr...

Full description

Bibliographic Details
Main Authors:	Chundi Gao, Huayao Li, Chao Zhou, Cun Liu, Jing Zhuang, Lijuan Liu, Changgang Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Endocrinology
Subjects:	HER2-positive breast cancer metabonomics prognostic risk scoring system lasso cox regression analysis survival prediction
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.813306/full

Similar Items

Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer
by: Chundi Gao, et al.
Published: (2020-04-01)

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
by: Chundi Gao, et al.
Published: (2018-11-01)

A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer
by: Xiaolu Zhang, et al.
Published: (2021-01-01)

Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis
by: Chundi Gao, et al.
Published: (2021-04-01)

Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System
by: Chundi Gao, et al.
Published: (2022-01-01)

7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis
by: Huayao Li, et al.
Published: (2019-12-01)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
by: Xuetong Shen, et al.
Published: (2023-09-01)

Identification and Validation of a Five-Gene Signature Associated With Overall Survival in Breast Cancer Patients
by: Xiaolong Wang, et al.
Published: (2021-08-01)

Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma
by: Jing ZHOU, et al.
Published: (2021-08-01)

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
by: Yubao Zhang, et al.
Published: (2021-11-01)

Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
by: Mingjun Yang, et al.
Published: (2020-11-01)

Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
by: Michelle D. Hackshaw, et al.
Published: (2021-08-01)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
by: Baoling Liu, et al.
Published: (2021-06-01)

SNP mutation‐related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database
by: Chundi Gao, et al.
Published: (2019-05-01)

A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy
by: Honghai Zhang, et al.
Published: (2024-02-01)

Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma
by: Jia You, et al.
Published: (2022-06-01)

Exploring Pathway-Based Group Lasso for Cancer Survival Analysis: A Special Case of Multi-Task Learning
by: Gabriela Malenová, et al.
Published: (2021-11-01)

Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
by: Minpu Zhang, et al.
Published: (2024-01-01)

The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method
by: Cun Liu, et al.
Published: (2019-10-01)

Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
by: Fu Li, et al.
Published: (2022-08-01)

A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma
by: Wang Z, et al.
Published: (2024-01-01)

Potential of cucurbitacin as an anticancer drug
by: Yan Li, et al.
Published: (2023-12-01)

Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
by: Yan Yao, et al.
Published: (2022-04-01)

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
by: Xu Teng, et al.
Published: (2023-06-01)

A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts
by: Jiaxing Lin, et al.
Published: (2020-08-01)

Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy
by: Qihang Shang, et al.
Published: (2024-01-01)

Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients
by: Yang Zheng, et al.
Published: (2022-04-01)

Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
by: Xiao-Ping Liu, et al.
Published: (2019-01-01)

Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent
by: Noah Simon, et al.
Published: (2011-03-01)

A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer
by: Hua X, et al.
Published: (2022-01-01)

A six-gene prognostic model predicts overall survival in bladder cancer patients
by: Liwei Wang, et al.
Published: (2019-09-01)

Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
by: Rémy Jardillier, et al.
Published: (2022-10-01)

Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas
by: Cun Liu, et al.
Published: (2019-05-01)

The construction of a novel prognostic prediction model for glioma based on GWAS-identified prognostic-related risk loci
by: Wei Jie, et al.
Published: (2024-03-01)

LASSO-Cox Modeling of Survival Using High-Resolution CT-Based Radiomic Features in a Cohort of COVID-19 Patients and Its Generalizability to Standard Image Reconstruction
by: Giulia Paolani, et al.
Published: (2022-11-01)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
by: Qiang Su, et al.
Published: (2021-09-01)

A prognostic nomogram for recurrence survival in post-surgical patients with varicose veins of the lower extremities
by: Hai Hu, et al.
Published: (2024-03-01)

Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data
by: Simon Klau, et al.
Published: (2018-09-01)

Tied Survival Times In Survival Analysis
by: Duru Karasoy, et al.
Published: (2017-06-01)

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients
by: Tingting Qi, et al.
Published: (2020-12-01)